Diabetic nephropathy: An epidemiological study based on proteinuria in a population of black African diabetics in Cotonou, Benin;Néphropathie diabétique: Une étude épidémiologique fondée sur la protéinurie dans une population de diabétiques noirs Africains à Cotonou, Bénin

Cahiers Sante

Volumn 11, Issue 2, 2001, Pages 105-109

  Djrolo, F ^a   Attolou, V G ^a   Avode, D G ^a   Houngbe, F ^a   Akpona, S ^a   Addra, B ^a   Kodjoh, N ^a  

^a UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BENIN; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE DURATION; EARLY DIAGNOSIS; FEMALE; HEMODIALYSIS; HUMAN; INSULIN TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEGRO; PROTEINURIA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BENIN; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROTEINURIA; SEX DISTRIBUTION; URBAN HEALTH;

EID: 0034954328     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections
2. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulindependent diabetic subjects
3. Diabetes and renal mortality in the United States
4. Effect of proteinuria on mortality in NIDDM
5. Cause-specific mortality in a population-based study of diabetes
6. Prospective study of microalbuminuria as predictor of mortality in NIDDM
7. Etiology and prognostic significance of albuminuria in diabetes
8. Microalbuminurie: Signification et intérêt
9. Recent advances in understanding mechanism and natural history of diabetic renal desease
10. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin dependent), diabetic nephropathy
11. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
12. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
13. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes
14. Ten years incidence of gross proteinuria in people with diabetes
15. Étude clinique du diabète sucré à Kinshasa
16. Audit of public sector primary diabetes care in Cape Town, south Africa: High prevalence of complication, uncontrolled hyperglycemia and hypertension
17. Incidence of gross proteinuria in older-onset diabetes: A population-based perspective
18. Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark
19. Des diabétiques qui s'ignorent: Résultats d'une activité de dépistage à Cotonou (Bénin)
20. Glucose control and the renal and retinal complications of insulin-dependent diabetes
21. Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in type 1 (insulin-dependent) diabetic patients
22. Glomerulosclerosis in type 2 (non-insulin-dependent) diabetes mellitus: Relationship to glycaemia in the University Group Diabetes Program (UGDP)
23. Determinants of progression of microalbuminuria in adolescents with IDDM
24. The effect of long-term intensified insulin treatment on the developpement of microvascular complications of diabetes mellitus
25. Declining indicence of nephropathy in insulin dependent diabetes mellitus
26. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: The Horn Study
27. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients
28. Influence of antihypertensive therapy on development and progression of diabetic glomerulopathy
29. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy